Docquity and Sumedang Regency launch an AI-driven platform to tackle critical health issues like Tuberculosis, Stunting, and Hypertension.
Docquity, a leading health tech company, has partnered with Sumedang Regency in Indonesia to launch the Puskesmas AI platform, a groundbreaking initiative aimed at improving healthcare outcomes for critical issues like Tuberculosis, Stunting, and Hypertension. This GenAI-driven platform is designed to assist healthcare professionals by providing real-time, credible data from trusted sources, including the Ministry of Health, WHO, and local government entities. The platform is fully compliant with Indonesian and European data protection regulations, ensuring patient information is secure.
The Puskesmas AI platform is equipped with advanced AI capabilities that allow healthcare professionals to access a comprehensive knowledge base, receive real-time answers to their queries, and enhance their decision-making process. The platform uses GenAI technology to analyze and generate insights from vast amounts of medical data, helping healthcare providers make more informed decisions. It is designed with a user-friendly interface, making it easy for healthcare professionals to navigate and utilize the information effectively.
The initiative, supported by local government leaders, aims to revolutionize healthcare in Sumedang by equipping healthcare professionals with the tools needed to address complex health challenges. The platform is part of a broader strategy to implement AI in public health, with plans to expand its use across West Java Province. Additionally, an Adherence Program is being introduced to monitor patient progress and ensure better health outcomes.